Patents Assigned to TUMOREND, LLC
  • Compositions, methods and treatments for inhibiting cell adhesion and virus binding and penetration
    Patent number: 12227788
    Abstract: Disclosed herein are glyco-decoy acceptor compositions that sidetrack or inhibit the activity of biosynthetic enzymes participating in synthesis of ligands binding at selectin, galectin and siglecs receptors; methods of their preparation and uses in drug discovery and in treatments of diseases.
    Type: Grant
    Filed: December 20, 2021
    Date of Patent: February 18, 2025
    Assignee: TumorEnd, LLC
    Inventor: Khushi L. Matta
  • COMPOSITIONS, METHODS AND TREATMENTS FOR INHIBITING CELL ADHESION AND VIRUS BINDING AND PENETRATION
    Publication number: 20220396823
    Abstract: Disclosed herein are glyco-decoy acceptor compositions that sidetrack or inhibit the activity of biosynthetic enzymes participating in synthesis of ligands binding at selectin, galectin and siglecs receptors; methods of their preparation and uses in drug discovery and in treatments of diseases.
    Type: Application
    Filed: December 20, 2021
    Publication date: December 15, 2022
    Applicant: TUMOREND, LLC
    Inventor: Khushi L. MATTA
  • Compositions, methods and treatments for inhibiting cell adhesion and virus binding and penetration
    Patent number: 11203776
    Abstract: Disclosed herein are glyco-decoy acceptor compositions that sidetrack or inhibit the activity of biosynthetic enzymes participating in synthesis of ligands binding at selectin, galectin and siglecs receptors; methods of their preparation and uses in drug discovery and in treatments of diseases.
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: December 21, 2021
    Assignee: TumorEnd, LLC
    Inventor: Khushi L. Matta
  • COMPOSITIONS, METHODS AND TREATMENTS FOR INHIBITING CELL ADHESION AND VIRUS BINDING AND PENETRATION
    Publication number: 20190017095
    Abstract: Disclosed herein are glyco-decoy acceptor compositions that sidetrack or inhibit the activity of biosynthetic enzymes participating in synthesis of ligands binding at selectin, galectin and siglecs receptors; methods of their preparation and uses in drug discovery and in treatments of diseases.
    Type: Application
    Filed: November 12, 2015
    Publication date: January 17, 2019
    Applicant: TUMOREND, LLC
    Inventor: Khushi L. MATTA